"リゲル" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonRigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update -...
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update PR Newswire
Rear Admiral Rigel D. Pirrone - navy.mil
Rear Admiral Rigel D. Pirrone navy.mil
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? Yahoo Finance
Rigel Provides Business Update and 2026 Outlook - BioSpace
Rigel enrols first subject in R289 Phase Ib expansion for MDS - Clinical Trials Arena
Rigel enrols first subject in R289 Phase Ib expansion for MDS Clinical Trials Arena
Rigel Pharmaceuticals Shows Rising Relative Strength; Still Shy Of Key Benchmark - Investor's Bus...
Rigel Pharmaceuticals Shows Rising Relative Strength; Still Shy Of Key Benchmark Investor's Business Daily
Douglas Jon Rigel - Richland Source
Douglas Jon Rigel Richland Source
Rigel Appoints Michael P. Miller to the Board of Directors - PR Newswire
Rigel Appoints Michael P. Miller to the Board of Directors PR Newswire
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial...
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update Yahoo Finance
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire
Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 Yahoo Finance
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lowe...
Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance - ...
Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance Yahoo Finance
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR...
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire
How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash F...
How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow Yahoo Finance
Rigel to Present at the Jefferies Global Healthcare Conference in London - PR Newswire
Rigel to Present at the Jefferies Global Healthcare Conference in London PR Newswire
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update PR Newswire
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology...
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/...
Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance
Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates Yahoo Finance
How Recent Developments Are Rewriting the Story for Rigel Pharmaceuticals - Yahoo Finance
How Recent Developments Are Rewriting the Story for Rigel Pharmaceuticals Yahoo Finance
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL) - Seeking Alpha
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL) Seeking Alpha
Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) Seeking Alpha
Rigel Pharmaceuticals CEO Raul Rodriguez on profitability and product growth - CNBC
Rigel Pharmaceuticals CEO Raul Rodriguez on profitability and product growth CNBC
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? Yahoo Finance
Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives - Yaho...
Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives Yahoo Finance
Rigel Pharma: Formulating A Game Plan For 2026 - Seeking Alpha
Rigel Pharma: Formulating A Game Plan For 2026 Seeking Alpha
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals...
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect - Yahoo Finance
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect Yahoo Finance
Rigel sets March 3 call to review 2025 results and business update - Stock Titan
Rigel sets March 3 call to review 2025 results and business update Stock Titan
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo...
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance Yahoo Finance
Is Rigel Pharmaceuticals (NASDAQ:RIGL) Using Too Much Debt? - simplywall.st
Is Rigel Pharmaceuticals (NASDAQ:RIGL) Using Too Much Debt? simplywall.st
Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has ...
Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has The Bull Case Changed? simplywall.st
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Ne...
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress PR Newswire
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribut...
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio GlobeNewswire
Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats - Seeking Alpha
Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats Seeking Alpha
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Stock with Affordable Growth and Strong Fundament...
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Stock with Affordable Growth and Strong Fundamentals ChartMill
Veteran biotech commercial leader Michael P. Miller joins Rigel board - Stock Titan
Veteran biotech commercial leader Michael P. Miller joins Rigel board Stock Titan
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? - Yahoo Finance
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? Yahoo Finance
Timothy Rigel Obituary (1949 - 2026) - Springfield, OH - Dayton Daily News - Legacy obituary
Timothy Rigel Obituary (1949 - 2026) - Springfield, OH - Dayton Daily News Legacy obituary
Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) - Seeking ...
Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) Seeking Alpha
Instagrammable eCooler Is Built Like a Tank: TRAVOCA Rigel 25 Dual Zone Review - GearJunkie
Instagrammable eCooler Is Built Like a Tank: TRAVOCA Rigel 25 Dual Zone Review GearJunkie
Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m - simp...
Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m simplywall.st
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Esti...
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates Yahoo Finance
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update PR Newswire
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Roc...
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% simplywall.st
Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo...
Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Yahoo Finance
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - Yahoo Finance
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? Yahoo Finance
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Yahoo Fi...
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT Yahoo Finance
Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? - Yahoo Finance
Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? Yahoo Finance
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount? - simplywall.st
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount? simplywall.st
Darrell Rigel, MD, MS, on Real-World Advancements in Actinic Keratosis Management - Dermatology T...
Darrell Rigel, MD, MS, on Real-World Advancements in Actinic Keratosis Management Dermatology Times
AllOutdoor Review – Travoca Rigel 45 Dual Zone eCooler - AllOutdoor.com
AllOutdoor Review – Travoca Rigel 45 Dual Zone eCooler AllOutdoor.com
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? - TradingView
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? TradingView
Maria Rigel • Director of Thus Spoke the Wind - Cineuropa
Institutional investors have a lot riding on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) with 65% o...
Institutional investors have a lot riding on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) with 65% ownership simplywall.st
Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Ou...
Alfonzo Rigel Obituary in Durham at American Cremation and Funeral Service - articobits.com
Alfonzo Rigel Obituary in Durham at American Cremation and Funeral Service articobits.com
Olga Rigel Obituary - Apex, NC - Dignity Memorial
Olga Rigel Obituary - Apex, NC Dignity Memorial
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Wh...
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why simplywall.st
Rigel Tepshi - Transfermarkt
Rigel Tepshi Transfermarkt
Look for the Witch Head nebula this Halloween night - EarthSky
Look for the Witch Head nebula this Halloween night EarthSky
Wartales Expansion: The Curse of Rigel DLC Release Date & Details - Tbreak Media
Wartales Expansion: The Curse of Rigel DLC Release Date & Details Tbreak Media
Rigel Announces Availability of REZLIDHIA™ (olutasidenib) in the U.S. for the Treatment of Adult ...
Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Pat...
Rigel Provides Business Update and 2025 Outlook - PR Newswire
Rigel Provides Business Update and 2025 Outlook PR Newswire
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® - PR Newswire
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® PR Newswire
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (RIGL) - Seeking Alpha
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (RIGL) Seeking Alpha
Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalki...
Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalking and threats' Berkeleyside
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - ...
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update PR Newswire
Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th A...
Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republi...
Rigel Pharmaceuticals Provides Business Update - PR Newswire
Rigel Pharmaceuticals Provides Business Update PR Newswire
5 Rigel Street, Melton, Vic 3337 - realestate.com.au
5 Rigel Street, Melton, Vic 3337 realestate.com.au
Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advanc...
Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advances PR Newswire
2024 October 31 - Rigel and the Witch Head Nebula - NASA (.gov)
2024 October 31 - Rigel and the Witch Head Nebula NASA (.gov)
Obituary for Vonda Mae Rigel - shirleyandstout.com
Obituary for Vonda Mae Rigel shirleyandstout.com
Rigel Pharmaceuticals Provides Business Update - PR Newswire
Rigel Pharmaceuticals Provides Business Update PR Newswire
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treat...
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel - Fierce Pharma
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel Fierce Pharma
Pfizer Turns Over Development Responsibility for Inhaled Asthma Therapy to Rigel - respiratory-th...
Pfizer Turns Over Development Responsibility for Inhaled Asthma Therapy to Rigel respiratory-therapy.com
Behind the badge: Artist/Sheriff Danny Rigel - WDAM-TV
Obituary for Cynthia S. Rigel - Hanneman Family Funeral Homes & Crematory
Obituary for Cynthia S. Rigel Hanneman Family Funeral Homes & Crematory
Rigel wins US approval of rival drug to Servier leukemia treatment - BioPharma Dive
Rigel wins US approval of rival drug to Servier leukemia treatment BioPharma Dive
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA - Fierce Biotech
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA Fierce Biotech
Rigel Announces Closing of Strategic Collaboration with Lilly - PR Newswire
Rigel Announces Closing of Strategic Collaboration with Lilly PR Newswire
2022 January 24 - Rigel and the Witch Head Nebula - NASA (.gov)
2022 January 24 - Rigel and the Witch Head Nebula NASA (.gov)
Rigel brings smart bathroom products, services to U.S. market - Hotel Management
Rigel brings smart bathroom products, services to U.S. market Hotel Management
2023 April 7 - Rigel Wide - NASA (.gov)
2023 April 7 - Rigel Wide NASA (.gov)
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercial...
Eyes of the Rigel - Literary Hub
Eyes of the Rigel Literary Hub
Rigel scores green light in AML just 4 months after buying asset from Forma - Fierce Pharma
Rigel scores green light in AML just 4 months after buying asset from Forma Fierce Pharma
Eli Lilly hands over $125M to Rigel with $835M in biobucks for RIPK1 inhibitors - Fierce Biotech
Eli Lilly hands over $125M to Rigel with $835M in biobucks for RIPK1 inhibitors Fierce Biotech
Rigel Review - Cruise Critic
Rigel Review Cruise Critic
Rigel Initiates Phase 1 Clinical Trial of R835, an IRAK1/4 Inhibitor for Autoimmune and Inflammat...
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., ...
A guide to star Rigel - BBC Sky at Night Magazine
A guide to star Rigel BBC Sky at Night Magazine
U.S. FDA approves Rigel Pharma's treatment for a type of leukemia - Reuters
U.S. FDA approves Rigel Pharma's treatment for a type of leukemia Reuters
Help from Orion - NASA Science (.gov)
Help from Orion NASA Science (.gov)
The Ongoing Struggle for the City: A Conversation with Rigel Sergent - Venezuelanalysis
The Ongoing Struggle for the City: A Conversation with Rigel Sergent Venezuelanalysis